Cargando…
2283. The Incidence and Risk Factors for Neurotoxicity in Patients on Ertapenem Therapy: a Retrospective Case- Control Study
BACKGROUND: Numerous reports have emerged about the neurotoxic effects of ertapenem. A recent study supports carbapenem use for the treatment of extended spectrum β-lactamase (ESBL)- producing Gram-negative bacteremia. This will likely bolster the use of ertapenem as it is a convenient choice to com...
Autores principales: | Fong, Raymond K C, Donoghue, Stephen G, Shafi, Humaira, Yen Tan, Seow, Boon Lee, Wee, Chiu Kit Wong, Edmund, Alalageri, Vijaya S, Seah, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810748/ http://dx.doi.org/10.1093/ofid/ofz360.1961 |
Ejemplares similares
-
2786. Characterizing Ertapenem Neurotoxicity: A Systematic Review
por: Mitaka, Hayato, et al.
Publicado: (2023) -
52. Direct Communication Improves Response Time to Acceptance of Antimicrobial Stewardship Interventions
por: Shafi, Humaira, et al.
Publicado: (2021) -
Ertapenem-Induced Neurotoxicity: A Literature Review of Clinical Characteristics and Treatment Outcomes
por: Wang, Chunjiang, et al.
Publicado: (2023) -
Ertapenem-induced neurotoxicity in an end-stage renal disease patient on intermittent haemodialysis: a case report
por: Shahar, Shamira, et al.
Publicado: (2022) -
Ertapenem-Induced Thrombocytosis
por: Docobo, Ramon A, et al.
Publicado: (2017)